BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 19234223)

  • 1. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells.
    Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT
    J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells.
    Chuang YH; Wang TC; Jen HY; Yu AL; Chiang BL
    J Immunol; 2011 Apr; 186(8):4687-92. PubMed ID: 21383248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
    Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
    J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma.
    Hachem P; Lisbonne M; Michel ML; Diem S; Roongapinun S; Lefort J; Marchal G; Herbelin A; Askenase PW; Dy M; Leite-de-Moraes MC
    Eur J Immunol; 2005 Oct; 35(10):2793-802. PubMed ID: 16180255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of nonclassical CD1d-restricted NK T cells induces airway hyperreactivity in beta 2-microglobulin-deficient mice.
    Koh YI; Kim HY; Meyer EH; Pichavant M; Akbari O; Yasumi T; Savage PB; DeKruyff RH; Umetsu DT
    J Immunol; 2008 Oct; 181(7):4560-4569. PubMed ID: 18802058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation.
    Vultaggio A; Nencini F; Pratesi S; Petroni G; Romagnani S; Maggi E
    Allergy; 2012 Oct; 67(10):1223-32. PubMed ID: 22882449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity.
    Lombardi V; Stock P; Singh AK; Kerzerho J; Yang W; Sullivan BA; Li X; Shiratsuchi T; Hnatiuk NE; Howell AR; Yu KO; Porcelli SA; Tsuji M; Kronenberg M; Wilson SB; Akbari O
    J Immunol; 2010 Feb; 184(4):2107-15. PubMed ID: 20083656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: intravenous Ig inhibits invariant NKT cell-mediated allergic airway inflammation through FcγRIIIA-dependent mechanisms.
    Araujo LM; Chauvineau A; Zhu R; Diem S; Bourgeois EA; Levescot A; Huerre M; Gombert JM; Bayry J; Daëron M; Bruhns P; Kaveri SV; Herbelin A
    J Immunol; 2011 Mar; 186(6):3289-93. PubMed ID: 21317388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model.
    Kim JO; Kim DH; Chang WS; Hong C; Park SH; Kim S; Kang CY
    J Allergy Clin Immunol; 2004 Dec; 114(6):1332-8. PubMed ID: 15577831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKT cell-dependent regulation of secondary antigen-specific, conventional CD4+ T cell immune responses.
    Shin Y; Hong C; Lee H; Shin JH; Hong S; Park SH
    J Immunol; 2010 May; 184(10):5589-94. PubMed ID: 20375305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity.
    Lee KA; Kang MH; Lee YS; Kim YJ; Kim DH; Ko HJ; Kang CY
    Cell Immunol; 2008 Jan; 251(1):50-5. PubMed ID: 18423430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity.
    Akbari O; Stock P; Meyer E; Kronenberg M; Sidobre S; Nakayama T; Taniguchi M; Grusby MJ; DeKruyff RH; Umetsu DT
    Nat Med; 2003 May; 9(5):582-8. PubMed ID: 12669034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A T(h)17-polarized cell population that has infiltrated the lung requires cells that convert to IFN-{gamma} production in order to induce airway hyperresponsiveness.
    Ashino S; Wakita D; Shiohama Y; Iwakura Y; Chamoto K; Ohkuri T; Kitamura H; Nishimura T
    Int Immunol; 2010 Jun; 22(6):503-13. PubMed ID: 20501609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production.
    Matsuda H; Takeda K; Koya T; Okamoto M; Shiraishi Y; Miyahara N; Dakhama A; Matsuda JL; Gapin L; Gelfand EW
    J Immunol; 2010 Jul; 185(1):253-62. PubMed ID: 20525882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells.
    Chen S; Ndhlovu LC; Takahashi T; Takeda K; Ikarashi Y; Kikuchi T; Murata K; Pandolfi PP; Riccardi C; Ono M; Sugamura K; Ishii N
    Eur J Immunol; 2008 Aug; 38(8):2229-40. PubMed ID: 18624295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.
    Akbari O; Stock P; Singh AK; Lombardi V; Lee WL; Freeman GJ; Sharpe AH; Umetsu DT; Dekruyff RH
    Mucosal Immunol; 2010 Jan; 3(1):81-91. PubMed ID: 19741598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.